Patents by Inventor Xuqing Yang

Xuqing Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor
    Patent number: 8703771
    Abstract: The invention provides a new kind of dihydroindene amide compounds of general formula I or their pharmaceutically acceptable salts or prodrug thereof which can be used as protein kinase inhibitor. The invention provides a preparation method of the kind of compounds, the pharmaceutical compositions containing the compounds, the method for preventing or curing the diseases related to the abnormity of activities of protein kinases, especially Abl, Bcr-Abl, c-Kit and PDGFR, using them as protein kinase inhibitor, and their preparation use of drug used for preventing or curing the diseases related to the abnormity of activities of protein kinases, especially Abl, Bcr-Abl, c-Kit and PDGFR.
    Type: Grant
    Filed: December 24, 2009
    Date of Patent: April 22, 2014
    Assignee: Harbin Gloria Pharmaceuticals Co., Ltd.
    Inventors: Xuqing Yang, Long Xue, Juan Luo
  • PREPARATION METHOD OF DIHYDROINDENE AMIDE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS THEREOF AND USE AS PROTEIN KINASES INHIBITOR
    Publication number: 20110319420
    Abstract: The invention provides a new kind of dihydroindene amide compounds of general formula I or their pharmaceutically acceptable salts or prodrug thereof which can be used as protein kinase inhibitor. The invention provides a preparation method of the kind of compounds, the pharmaceutical compositions containing the compounds, the method for preventing or curing the diseases related to the abnormity of activities of protein kinases, especially Abl, Bcr-Abl, c-Kit and PDGFR, using them as protein kinase inhibitor, and their preparation use of drug used for preventing or curing the diseases related to the abnormity of activities of protein kinases, especially Abl, Bcr-Abl, c-Kit and PDGFR.
    Type: Application
    Filed: December 24, 2009
    Publication date: December 29, 2011
    Applicant: HARBIN GLORIA PHARMACEUTICALS CO., LTD
    Inventors: Xuqing Yang, Long Xue, Juan Luo
  • Dicarboxylato diammine platinum derivatives and compositions comprising them as anti-tumor agents
    Patent number: 6699901
    Abstract: The present invention relates to an antitumor derivative of double dicarboxylic acid diaminoplatin complex of formula (I): wherein R1 and R2 have the meanings defined in the specification, also relates to a process for preparation thereof, to an antitumor pharmaceutical composition containing the same, and further to application of the derivative in making antitumor pharmaceutics. The composition is a new generation of safe and effective antitumor drug, which has advantages such as low toxicity, broad antitumor spectrum, high antitumor activity, good solubility in water and fine stability in aqueous solution, selective killing of cancer cells without damaging normal cells, etc.
    Type: Grant
    Filed: August 12, 2002
    Date of Patent: March 2, 2004
    Inventors: Xuqing Yang, Zhenyun Yang, Yingwu Yin, Weichuan Cui, Jinli Yang, Chenxia Zhu